Episode Details
Back to Episodes
India’s Next Big CDMO Winner?
Published 2 months ago
Description
In this episode, we break down Sai Life Sciences, the fourth company in our 20 Unique Businesses series, where we explore high-quality companies with strong competitive advantages.
Sai Life Sciences is a unique CRDMO player in the pharma sector that earns 100% of its revenue from global innovator companies like Pfizer and AbbVie.
We explain how the CDMO and CRO industry works, why integration from research to manufacturing is a powerful business model, and how this company stands out from others in the space.
We also cover industry growth, business segments, key molecules, growth triggers, and risks, giving you a clear and simple understanding of this business.